Annexon, Inc. (ANNX)
4.96
-0.14
(-2.75%)
USD |
NASDAQ |
Feb 20, 13:40
Annexon EPS Diluted (Quarterly) : -0.3683 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Savara, Inc. | -0.1366 |
| Marker Therapeutics, Inc. | -0.1193 |
| ADMA Biologics, Inc. | 0.1489 |
| Spruce Biosciences, Inc. | -14.58 |
| Arrivent BioPharma, Inc. | -0.8345 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.92M |
| Total Expenses (Quarterly) | 54.92M |
| Enterprise Value | 598.40M |
| Earnings Yield | -28.39% |
| Normalized Earnings Yield | -28.39 |